References
- Rini BI, Escudier B, Tomczak P, Kaprin A, Szczylik C, Hutson TE, et al. Comparative effectiveness of axitinib versus sorafenib in advanced renal cell carcinoma (AXIS): A randomised phase 3 trial. Lancet 2011;378:1931–9.
- Sheikh AS, Ali K, Mazhar S. Acute aortic syndrome. Circulation 2013;128:1122–7.
- Lenihan DJ, Kowey PR. Overview and management of cardiac adverse events associated with tyrosine kinase inhibitors. Oncologist 2013;18:900–8.
- Serrano C, Suarez C, Andreu J, Carles J. Acute aortic dissection during sorafenib-containing therapy. Ann Oncol 2010;21:181–2.
- Edeline J, Laguerre B, Rolland Y, Patard JJ. Aortic dissection in a patient treated by sunitinib for metastatic renal cell carcinoma. Ann Oncol 2010;21:186–7.